<DOC>
	<DOCNO>NCT00327106</DOCNO>
	<brief_summary>The purpose study assess efficacy tranexamic acid hip fracture surgery reduction allogeneic red blood cell transfusion .</brief_summary>
	<brief_title>Tranexamic Acid HIp Fracture Surgery ( THIF Study )</brief_title>
	<detailed_description>Studies hip knee arthroplasty ( schedule surgery ) show tranexamic acid decrease allogeneic red blood cell transfusion . In hip fracture surgery , emergent procedure , transfusion frequent . Transfusion increase adverse event postoperative bacterial infection venous thrombosis . The purpose study assess efficacy tranexamic acid , anti-fibrinolytic agent , hip fracture surgery reduction allogeneic red blood cell transfusion . The trial also evaluate reduction transfusion associate less postoperative infection without increase thrombotic risk . Patients isolated hip fracture le 48 hour randomize either tranexamic acid 15mg/kg IV skin incision three hour later saline.Patients receive fondaparinux prophylaxis venous thrombosis .</detailed_description>
	<mesh_term>Fractures , Bone</mesh_term>
	<mesh_term>Hip Fractures</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>Patient require surgery isolate hip fracture le 48 hour Contraindication tranexamic acid Contraindication fondaparinux Contraindication general anesthesia associate femoral nerve block pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>hip fracture</keyword>
	<keyword>transfusion</keyword>
	<keyword>tranexamic acid</keyword>
	<keyword>fondaparinux</keyword>
</DOC>